Physician profile
Joanna Mitri
NPI 1356582845
$51,783.33
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,899 · 2021: $37.68 · 2022: $16K · 2023: $29K · 2024: $50.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $2,107 · Food and Beverage: $1,045 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,450.00 |
| Travel and Lodging | $2,107.49 |
| Food and Beverage | $1,044.85 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $44,273.30 | 2019-2023 | |
| Eli Lilly and Company | $4,950.00 | 2023 | |
| Novo Nordisk As | $1,530.00 | 2022 | |
| Orpyx Medical Technologies INC. | $500.00 | 2023 | |
| Insulet Corporation | $155.12 | 2022 | |
| Janssen Biotech, INC. | $135.66 | 2022 | |
| Mannkind Corporation | $118.80 | 2022 | |
| Genzyme Corporation | $50.38 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.68 | 2021 | |
| Abbott Laboratories | $32.39 | 2023 | Freestyle Libre 3 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Mitri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.